DENALI THERAPEUTICS INC's ticker is DNLI and the CUSIP is 24823R105. A total of 211 filers reported holding DENALI THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 4.43 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $54,049,940 | -30.1% | 2,619,968 | 0.0% | 3.92% | +13.7% |
| Q2 2023 | $77,315,256 | +28.1% | 2,619,968 | 0.0% | 3.45% | +47.1% |
| Q1 2023 | $60,364,063 | -17.2% | 2,619,968 | 0.0% | 2.35% | +0.9% |
| Q4 2022 | $72,861,310 | -9.4% | 2,619,968 | 0.0% | 2.33% | -31.3% |
| Q3 2022 | $80,407,000 | +4.3% | 2,619,968 | 0.0% | 3.38% | +16.5% |
| Q2 2022 | $77,106,000 | -8.5% | 2,619,968 | 0.0% | 2.90% | +46.8% |
| Q1 2022 | $84,284,000 | -27.9% | 2,619,968 | 0.0% | 1.98% | +9.5% |
| Q4 2021 | $116,851,000 | -15.2% | 2,619,968 | -4.0% | 1.81% | +25.3% |
| Q3 2021 | $137,742,000 | -35.7% | 2,730,263 | 0.0% | 1.44% | -47.3% |
| Q2 2021 | $214,162,000 | +37.4% | 2,730,263 | 0.0% | 2.74% | +9.5% |
| Q1 2021 | $155,898,000 | -31.8% | 2,730,263 | 0.0% | 2.50% | -40.0% |
| Q4 2020 | $228,687,000 | +6.7% | 2,730,263 | -54.3% | 4.16% | -29.7% |
| Q3 2020 | $214,273,000 | +11.0% | 5,980,263 | -25.1% | 5.92% | +5.6% |
| Q2 2020 | $192,963,000 | +38.1% | 7,980,263 | 0.0% | 5.61% | -14.4% |
| Q1 2020 | $139,734,000 | +0.5% | 7,980,263 | 0.0% | 6.55% | -15.7% |
| Q4 2019 | $139,016,000 | +13.3% | 7,980,263 | -0.3% | 7.77% | +15.8% |
| Q3 2019 | $122,648,000 | -26.2% | 8,005,747 | 0.0% | 6.71% | -6.7% |
| Q2 2019 | $166,199,000 | -10.6% | 8,005,747 | 0.0% | 7.19% | +2.3% |
| Q1 2019 | $185,893,000 | +0.9% | 8,005,747 | -10.2% | 7.04% | -21.8% |
| Q4 2018 | $184,261,000 | -5.0% | 8,918,749 | 0.0% | 9.00% | -29.8% |
| Q3 2018 | $193,894,000 | +42.6% | 8,918,749 | 0.0% | 12.82% | -50.8% |
| Q2 2018 | $136,011,000 | -22.5% | 8,918,749 | 0.0% | 26.05% | -48.8% |
| Q1 2018 | $175,610,000 | +25.9% | 8,918,749 | 0.0% | 50.92% | +43.9% |
| Q4 2017 | $139,489,000 | – | 8,918,749 | – | 35.37% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Crestline Management, LP | 7,460,732 | $240,012,000 | 28.78% |
| Casdin Capital, LLC | 1,500,000 | $48,255,000 | 2.16% |
| Flagship Pioneering Inc. | 2,619,968 | $84,284,000 | 1.98% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 38,000 | $8,192,000 | 1.85% |
| Yiheng Capital Management, L.P. | 1,014,684 | $32,642,000 | 1.49% |
| SECTORAL ASSET MANAGEMENT INC | 207,100 | $6,662,000 | 1.18% |
| Artal Group S.A. | 600,000 | $19,302,000 | 0.81% |
| GILDER GAGNON HOWE & CO LLC | 2,619,217 | $84,260,000 | 0.78% |
| Temasek Holdings (Private) Ltd | 5,369,487 | $172,736,397 | 0.73% |
| BRANDYWINE MANAGERS, LLC | 9,601 | $309,000 | 0.53% |